Insider Transactions in Q2 2024 at Johnson & Johnson (JNJ)
Insider Transaction List (Q2 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
May 22
2024
|
Joseph J Wolk Exec VP, CFO |
SELL
Bona fide gift
|
Direct |
55
-0.08%
|
-
|
|
May 01
2024
|
John C Reed EVP, Innovative Medicine, R&D |
SELL
Payment of exercise price or tax liability
|
Direct |
10,984
-48.69%
|
$1,581,696
$144.59 P/Share
|
|
May 01
2024
|
John C Reed EVP, Innovative Medicine, R&D |
BUY
Exercise of conversion of derivative security
|
Direct |
22,255
+49.66%
|
-
|